-
Accumen has acquired three companies this year, allowing it to generate significant additional value for hospitals and health system, commercial laboratory, and health plan clients
Nov 19, 2019
-
Nov 12, 2019
-
Nov 12, 2019
-
Proscia, a leading provider of digital pathology software, announces the Fall 2019 release of its Concentriq platform, along with a global collaboration with Dell Technologies, to help life sciences companies accelerate the adoption of digital pathology at an enterprise scale.
Nov 11, 2019
-
Proscia, a leading provider of digital pathology software, has been named to the CNBC Upstart 100, an exclusive list of venture-backed startups that have the potential to transform industries and become tomorrow’s household names. Proscia was selected from hundreds of nominees globally for its work towards delivering artificial intelligence applications to improve the quality and speed of cancer diagnosis.
Nov 11, 2019
-
QuantuMDx & SpeeDx Pty Ltd are collaborating with FIND to assess the feasibility of developing rapid, low-cost, point of care diagnostic tests for common STIs.
Nov 7, 2019
-
UK-based Bond Digital Health is predicting significant growth in 2020 on the back of inroads made into the global diagnostics market. The digital health company, based in Cardiff, Wales, has doubled its 2020 revenue predictions from £1.5m ($1.93m US) to more than £3m ($3.86m US).
Nov 4, 2019
-
Experienced pharma business strategist excited by potential of glycoscience.
Oct 29, 2019
-
Oct 30, 2019
-
Presentations demonstrate how to employ real-world evidence to compare the cost-effectiveness and therapeutic benefit of different medical interventions
Oct 31, 2019
-
ECGmd is now recognized as a medical device in Europe, capable of providing medical-grade ECG output from Shimmer’s wearable sensor
Nov 3, 2019
-
New features include upgraded refreshments and entertainment options, improved compensation, increased donor educational materials, and an expanded company website
Nov 3, 2019
-
Certara will host two Phoenix WinNonlin™ Lunch and Learns and also lead 18 workshop, presentation and poster sessions on model-informed drug development
Nov 3, 2019
-
Oct 28, 2019
-
Today, Thermo Fisher Scientific announced a co-marketing agreement with Genialis, a data science company leading the industry in RNA-based discovery, that aims to streamline data analysis for high-throughput genome sequencing. Together, these companies ae addressing one of the most problematic bottlenecks in the next-generation sequencing workflow – Informatics.
The agreement will create an analysis workflow integrating the Invitrogen Collibri Stranded RNA Library Prep Kit for Illumina Systems with Genialis Expressions analysis software to support the data analysis needs of Thermo Fisher Collibri customers, effectively shortening the time from raw data to discovery.
Oct 28, 2019
-
Sep 30, 2019
-
In her new position, Ms. Ball will be responsible for providing leadership and strategic direction on operational and business decisions, including growth planning, business and organizational development, risk management, and quality control.
Oct 1, 2019
-
The Simcyp Consortium was created as a collaborative research center to develop best practices and progress physiologically-based pharmacokinetic (PBPK) modeling and simulation, the science of studying drug handling by the body in computer-generated, virtual patients. Today, it counts 37 leading biopharmaceutical companies among its members and is a global authority on mechanistic PBPK modeling and simulation. Consortium members work together in a pre-competitive environment to progress model-informed drug development and create annual updates to Certara’s Simcyp Population-based Simulator.
Oct 15, 2019
-
BioIVT, a leading provider of research models and services for drug and diagnostic development, has acquired PPA Research Group, Inc., a human hematologic product provider, based in Gray, TN. This acquisition will significantly expand BioIVT’s immunology and disease-state product portfolios, enhancing its ability to support immuno-oncology and cell therapy researchers.
Oct 15, 2019
-
A team of researchers from Letterkenny Institute of Technology (LYIT) and Letterkenny University Hospital (LUH) in Ireland will be using Shimmer’s Verisense™ continuous monitoring platform to study fatigue accurately in individuals with breast cancer, enabling the development of better predictive models and interventions.
Oct 9, 2019